Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 276

1.

Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young Adults.

Cressey TR, Yogev R, Wiznia A, Hazra R, Jean-Philippe P, Graham B, Gonzalez A, Britto P, Carey VJ, Fletcher CV, Acosta EP; IMPAACT P1058A Team.

J Pediatric Infect Dis Soc. 2016 Apr 21. pii: piw017. [Epub ahead of print]

PMID:
27103489
2.

Computerized vital signs analysis and late onset infections in extremely low gestational age infants.

Mithal LB, Yogev R, Palac H, Gur I, Mestan KK.

J Perinat Med. 2016 Feb 4. pii: /j/jpme.ahead-of-print/jpm-2015-0362/jpm-2015-0362.xml. doi: 10.1515/jpm-2015-0362. [Epub ahead of print]

PMID:
26845716
3.

Antiretroviral Therapy for Nevirapine-Exposed Children With HIV Infection.

Yogev R.

JAMA. 2015 Nov 3;314(17):1801-2. doi: 10.1001/jama.2015.13763. No abstract available.

PMID:
26529157
4.

Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.

Purswani MU, Karalius B, Yao TJ, Schmid DS, Burchett SK, Siberry GK, Patel K, Van Dyke RB, Yogev R; Pediatric HIV/AIDS Cohort Study PHACS.

Clin Infect Dis. 2016 Jan 1;62(1):106-14. doi: 10.1093/cid/civ734. Epub 2015 Sep 18.

PMID:
26385992
5.

Default Mode Connectivity in Youth With Perinatally Acquired HIV.

Herting MM, Uban KA, Williams PL, Gautam P, Huo Y, Malee K, Yogev R, Csernansky J, Wang L, Nichols S, Van Dyke R, Sowell ER.

Medicine (Baltimore). 2015 Sep;94(37):e1417. doi: 10.1097/MD.0000000000001417.

6.

Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.

Coelingh K, Olajide IR, MacDonald P, Yogev R.

Expert Rev Vaccines. 2015;14(10):1331-46. doi: 10.1586/14760584.2015.1078732. Epub 2015 Sep 7.

PMID:
26372891
7.

White matter microstructure among youth with perinatally acquired HIV is associated with disease severity.

Uban KA, Herting MM, Williams PL, Ajmera T, Gautam P, Huo Y, Malee KM, Yogev R, Csernansky JG, Wang L, Nichols SL, Sowell ER; Pediatric HIVAIDS Cohort and the Pediatric Imaging, Neurocognition, and Genetics Studies.

AIDS. 2015 Jun 1;29(9):1035-44. doi: 10.1097/QAD.0000000000000648.

PMID:
26125138
8.

Re-evaluating the New Committee on Infectious Diseases Recommendations for Palivizumab Use in Premature Infants.

Yogev R, Krilov LR, Fergie JE, Weiner LB.

Pediatr Infect Dis J. 2015 Sep;34(9):958-60. doi: 10.1097/INF.0000000000000808. No abstract available.

PMID:
26107347
9.

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.

Siberry GK, Jacobson DL, Kalkwarf HJ, Wu JW, DiMeglio LA, Yogev R, Knapp KM, Wheeler JJ, Butler L, Hazra R, Miller TL, Seage GR 3rd, Van Dyke RB, Barr E, Davtyan M, Mofenson LM, Rich KC; Pediatric HIV/AIDS Cohort Study.

Clin Infect Dis. 2015 Sep 15;61(6):996-1003. doi: 10.1093/cid/civ437. Epub 2015 Jun 9.

PMID:
26060285
10.

Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots.

Gonzalez D, Melloni C, Poindexter BB, Yogev R, Atz AM, Sullivan JE, Mendley SR, Delmore P, Delinsky A, Zimmerman K, Lewandowski A, Harper B, Lewis KC, Benjamin DK Jr, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act--Pediatric Trials Network Administrative Core Committee.

Bioanalysis. 2015;7(9):1137-49. doi: 10.4155/bio.15.38.

11.

Antiretroviral Drugs in Meconium: Detection for Different Gestational Periods of Exposure.

Himes SK, Tassiopoulos K, Yogev R, Huestis MA; Pediatric HIV/AIDS Cohort Study (PHACS).

J Pediatr. 2015 Aug;167(2):305-11.e3. doi: 10.1016/j.jpeds.2015.04.062. Epub 2015 May 19.

PMID:
26001315
12.

Early viral suppression improves neurocognitive outcomes in HIV-infected children.

Crowell CS, Huo Y, Tassiopoulos K, Malee KM, Yogev R, Hazra R, Rutstein RM, Nichols SL, Smith RA, Williams PL, Oleske J, Muller WJ; PACTG 219C Study Team and the Pediatric HIVAIDS Cohort Study (PHACS).

AIDS. 2015 Jan 28;29(3):295-304. doi: 10.1097/QAD.0000000000000528.

13.

Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012.

Rough K, Tassiopoulos K, Kacanek D, Griner R, Yogev R, Rich KC, Seage GR 3rd; Pediatric HIVAIDS Cohort Study.

AIDS. 2015 Jan 2;29(1):117-23. doi: 10.1097/QAD.0000000000000503.

14.

Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants.

Forbes ML, Kumar VR, Yogev R, Wu X, Robbie GJ, Ambrose CS.

Hum Vaccin Immunother. 2014;10(10):2789-94. doi: 10.4161/hv.29635.

PMID:
25483663
15.

Clinical characteristics and genotypes of rotavirus in adults.

Anderson EJ, Shippee DB, Tate JE, Larkin B, Bregger MD, Katz BZ, Noskin GA, Sederdahl BK, Shane AL, Parashar UD, Yogev R.

J Infect. 2015 Jun;70(6):683-7. doi: 10.1016/j.jinf.2014.11.012. Epub 2014 Dec 4. No abstract available.

PMID:
25481405
16.

Multicenter clinical evaluation of the novel Alere™ i Influenza A&B isothermal nucleic acid amplification test.

Bell J, Bonner A, Cohen DM, Birkhahn R, Yogev R, Triner W, Cohen J, Palavecino E, Selvarangan R.

J Clin Virol. 2014 Sep;61(1):81-6. doi: 10.1016/j.jcv.2014.06.001. Epub 2014 Jun 7.

17.

Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.

Gonzalez D, Melloni C, Yogev R, Poindexter BB, Mendley SR, Delmore P, Sullivan JE, Autmizguine J, Lewandowski A, Harper B, Watt KM, Lewis KC, Capparelli EV, Benjamin DK Jr, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee.

Clin Pharmacol Ther. 2014 Oct;96(4):429-37. doi: 10.1038/clpt.2014.134. Epub 2014 Jun 20.

18.

Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.

Crowell CS, Malee KM, Yogev R, Muller WJ.

Rev Med Virol. 2014 Sep;24(5):316-31. doi: 10.1002/rmv.1793. Epub 2014 May 8. Review.

PMID:
24806816
19.

Long-term highly suppressed HIV-infected children and adolescents with negative rapid HIV tests due to significant antibody loss.

Merchant M, Wright M, Kabat W, Yogev R.

J Clin Virol. 2014 Mar;59(3):172-6. doi: 10.1016/j.jcv.2013.11.012. Epub 2013 Dec 5.

PMID:
24440176
20.

Improved access to early infant diagnosis is a critical part of a child-centric prevention of mother-to-child transmission agenda.

Ghadrshenas A, Ben Amor Y, Chang J, Dale H, Sherman G, Vojnov L, Young P, Yogev R; Child Survival Working Group of the Interagency Task Team on the Prevention and Treatment of HIV infection in Pregnant Women, Mothers and Children.

AIDS. 2013 Nov;27 Suppl 2:S197-205. doi: 10.1097/QAD.0000000000000104. Review.

PMID:
24361629
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk